Magnetic Patents (Class 436/526)
  • Patent number: 10684280
    Abstract: A toner composite material includes toner particles that include a sulfonated polyester and a wax and metal nanoparticles disposed on the surface of the toner particles. A method includes providing such toner composite materials, fusing the material to a substrate and covalently linking a ligand to the surface of the silver nanoparticles via a thiol, carboxylate, or amine functional group. Detection strips include a substrate and such toner composite materials fused on the substrate.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: June 16, 2020
    Assignee: XEROX CORPORATION
    Inventors: Valerie M. Farrugia, Wendy Chi, Sandra J. Gardner
  • Patent number: 10557174
    Abstract: Methods and systems for quantification of a target nucleic acid in a sample are provided. The method includes forming a plurality of discrete sample portions. Each of the plurality of discrete sample portions comprising a portion of the sample, and a reaction mixture. The method further includes amplifying the plurality of discrete sample portions to form a plurality of discrete processed sample portions. At least one discrete processed sample portion containing nucleic acid amplification reaction products. Fluorescence signals are detected from the at least one of the plurality of discrete processed sample portions to determine a presence of the at least one target nucleic acid. The method also includes determining the respective volumes of the plurality of the plurality of discrete processed sample portions, and estimating the number of copies-per-unit-volume of the at least one target nucleic acid in the sample.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: February 11, 2020
    Assignee: Life Technologies Corporation
    Inventors: Gordon A. Janaway, Mark Andersen, Kornelija Zgonc, Michael C. Pallas, Marcin Sikora, Casey R. McFarland, Ferrier N. Le, Haopeng Wang, Jian Gong, Gothami Padmabandu
  • Patent number: 10488408
    Abstract: The application relates to a method for detecting a target in a sample suspected of containing the target. The method comprises contacting the sample and a first binding molecule attached to a magnetic particle with a second binding molecule attached to a solid support. The first binding molecule is capable of binding to the second binding molecule, and the target is capable of interfering with this binding. Magnetic force is applied to bring the magnetic particle into close proximity with the solid support. The number of magnetic particles bound to the solid support is detected.
    Type: Grant
    Filed: April 27, 2007
    Date of Patent: November 26, 2019
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Thea Van Der Wijk, Eduard Gerard Marie Pelssers, Jessica Amadio
  • Patent number: 10451599
    Abstract: A method of detecting a metal ion in a protein-containing sample includes adding a protein degrading enzyme to the protein-containing sample to form an enzyme degradation product, adding an acid to the enzyme degradation product to provide a mixture, filtering the mixture to provide a supernatant, extracting the supernatant with an organic solvent to remove organic solvent soluble byproducts to provide a washed aqueous layer, and detecting the metal ion in the washed aqueous layer. The method is amenable to the detection of heavy metal ions in complex products such as milk. A kit includes reagents for performing the method.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: October 22, 2019
    Assignee: ZEPTO LIFE TECHNOLOGY, LLC
    Inventors: Joy Sinha, Gerson Aguirre
  • Patent number: 10444240
    Abstract: A ratio of rare cells to non-rare cells in a blood sample suspected of containing rare cells and non-rare cells is enhanced. A treated blood sample is prepared by providing in combination the blood sample, a platelet deactivation agent, a fibrin-formation-arresting agent and fibrin in an amount sufficient to cause a predetermined level of agglutination of the rare cells. The treated blood sample is then contacted with a porous matrix such that agglutinated rare cells are preferentially retained on the porous matrix. The rare cells may then be identified.
    Type: Grant
    Filed: March 26, 2014
    Date of Patent: October 15, 2019
    Assignee: SIEMENS HEALTHCARE DIAGNOSTICS, INC.
    Inventor: Michael Pugia
  • Patent number: 10422796
    Abstract: A method for measuring fibroblast growth factor-23 (FGF-23) in a sample, which comprise the following steps: (1) reacting, in an aqueous medium, FGF-23 in a sample with magnetic particles, a first antibody or a fragment thereof which binds to FGF-23, and a second antibody or a fragment thereof which binds to FGF-23, to form on the magnetic particles an immunocomplex comprising the first antibody or a fragment thereof which binds to FGF-23, FGF-23, and the second antibody or a fragment thereof which binds to FGF-23; (2) collecting the magnetic particles in the reaction mixture after step (1) by magnetic force, and separating the magnetic particles collected by magnetic force from the other components; and (3) measuring the immunocomplex on the magnetic particles separated in step (2). The present invention provides a method for measuring FGF-23 in a sample, which have a high sensitivity and have a wide measurement range.
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: September 24, 2019
    Assignee: KYOWA MEDEX CO., LTD.
    Inventors: Koji Uzawa, Emiko Suzuki, Kazuyuki Ikeda, Kazuki Morita
  • Patent number: 10384203
    Abstract: The invention provides devices that improve tests for detecting specific cellular, viral, and molecular targets in clinical, industrial, or environmental samples. The invention permits efficient detection of individual microscopic targets at low magnification for highly sensitive testing. The invention does not require washing steps and thus allows sensitive and specific detection while simplifying manual operation and lowering costs and complexity in automated operation. In short, the invention provides devices that can deliver rapid, accurate, and quantitative, easy-to-use, and cost-effective tests.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: August 20, 2019
    Assignee: First Light Biosciences, Inc.
    Inventors: Greg Yantz, Don Straus, Gordon Siek, Damon DeHart
  • Patent number: 10352932
    Abstract: In one aspect, presence and/or level of an analyte within a sample is determined by use of a construct comprising a magnetic moiety and a fluorescent moiety. In one embodiment, the construct is magnetically migrated to a transparent surface and then dragged along the surface. In one aspect, an evanescent field is applied and changes in the diffusional or rotational properties of the fluorescent moiety as it migrates in and out of the evanescent field are measured by changes in its fluorescent emission, providing a measure of the interaction between the construct and a component of the sample.
    Type: Grant
    Filed: October 16, 2015
    Date of Patent: July 16, 2019
    Inventor: Christopher Gordon Atwood
  • Patent number: 10261076
    Abstract: Small molecule analytes (less than 1000 Daltons) in a fluid sample are detected using a competitive assay in a magnetic biosensor. The fluid sample is added to a biosensor detection chamber together with detection probes and magnetic tags which bind to the detection probes. The magnetic biosensor is functionalized with a capture probe that shares an epitope with the analytes, and the detection probe is capable of binding the epitope shared by the analytes and the capture probe, so that the presence of the analyte prevents detection probes (and magnetic tags) from binding to the biosensor. By measuring the binding of the magnetic tags to the magnetic biosensor, an amount of analytes in the solution is determined.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: April 16, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Tyler O'Brien Shultz, Jung-Rok Lee, Shan X. Wang
  • Patent number: 10240186
    Abstract: Methods, microfluidic devices, and instruments for magnetic separation of particles from a fluid are described. Examples include microfluidic devices having a removable portion. Examples include microfluidic devices having one or more regions of reduced fluid velocity. Examples further including instruments having pneumatic interfaces. Examples further includes instruments having controllable magnets, imaging components, or combinations thereof.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: March 26, 2019
    Assignee: FLUXION BIOSCIENCES, INC.
    Inventors: Cristian Ionescu-Zanetti, Joshua Tanner Nevill, Michael Schwartz, Carolyn G. Conant, Roger Rudoff
  • Patent number: 10203326
    Abstract: A method of detecting a target substance, containing the steps of: incorporating labeling particles into a test liquid containing an analyte; heating the test liquid; irradiating the test liquid with excitation light, and detecting the target substance contained in the test liquid depending on a state of light emission of the labeling particles; wherein an aggregation state of the labeling particles is changed by the heating step; and wherein the labeling particles have a thermoresponsive polymer on a surface of a composite particle containing a magnetic material and a fluorescent material, and further have a biomolecule having properties of binding with the target substance.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: February 12, 2019
    Assignee: FURUKAWA ELECTRIC CO., LTD.
    Inventors: Masayuki Fukushima, Michio Ohkubo, Kazutomi Miyoshi, Masataka Nishida
  • Patent number: 9913917
    Abstract: The invention relates to highly fluorescent metal oxide nanoparticles to which biomolecules and other compounds can be chemically linked to form biocompatible, stable optical imaging agents for in vitro and in vivo applications. The fluorescent metal oxide nanoparticles may also be used for magnetic resonance imaging (MRI), thus providing a multi modality imaging agent.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: March 13, 2018
    Assignee: VisEn Medical, Inc.
    Inventors: Kevin Groves, Milind Rajopadhye
  • Patent number: 9878327
    Abstract: This disclosure describes microfluidic devices that include one or more magnets, each magnet being operable to emit a magnetic field; and a magnetizable layer adjacent to the one or more magnets, in which the magnetizable layer is configured to induce a gradient in the magnetic field of at least one of the magnets. For example, the gradient can be at least 103 T/m at a position that is at least 20 ?m away from a surface of the magnetizable layer. The magnetizable layer includes a first high magnetic permeability material and a low magnetic permeability material arranged adjacent to the high magnetic permeability material. The devices also include a microfluidic channel arranged on a surface of the magnetizable layer, wherein a central longitudinal axis of the microfluidic channel is arranged at an angle to or laterally offset from an interface between the high magnetic permeability material and the low magnetic permeability material.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: January 30, 2018
    Assignee: The General Hospital Corporation
    Inventors: Kyle C. Smith, Ramin Haghgooie, Thomas Alan Barber, Ismail Emre Ozkumur, Ravi Kapur, Mehmet Toner
  • Patent number: 9869674
    Abstract: The invention relates to a method for determining the presence of an analyte by means of a distribution of small magnetic particles. According to said method, the magnetizations of the small particles are oriented in relation to each other by means of an outer magnetic focusing field; once the focussing field has been terminated, the magnetizations of the small particles are rotated asynchronously to the magnetic field by means of an outer magnetic field of suitable field intensity and rotational frequency, which rotates about a longitudinal axis (z); the temporal course of the superpositioned transverse magnetization of the set of particles is detected; and the presence of the analyte is deduced from the detected temporal course. The invention also relates to a corresponding device (1).
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: January 16, 2018
    Assignees: Hochschule für angewandte Wissenschaften Fachhochschule Würzburg-Schweinfurt, Julius-Maximilians-Universität-Würzburg
    Inventors: Martin Rueckert, Volker C. Behr, Thomas Kampf
  • Patent number: 9851308
    Abstract: Methods of detecting very low levels of targets, such as cells, are provided. In some embodiments, for example, the methods can detect bacteria present in a sample at concentrations less than 25 cells/mL. The method involves detecting nanoparticle aggregation in the absence of the target.
    Type: Grant
    Filed: November 18, 2011
    Date of Patent: December 26, 2017
    Assignee: Wisconsin Alumni Research Foundation (WARF)
    Inventors: Sundaram Gunasekaran, Seok won Lim
  • Patent number: 9823316
    Abstract: A magnetic biosensor can include a magnetic stack comprising a free layer, a fixed layer, and a nonmagnetic layer between the free layer and the fixed layer. At least one of the free layer or the fixed layer may have a magnetic moment oriented out of a major plane of the free layer or the fixed layer, respectively, in an absence of an external magnetic field. The magnetic biosensor also may include a sample container disposed over the magnetic stack, a plurality of capture antibodies attached to a bottom surface of the sample container above the magnetic stack, and a magnetic field generator configured to generate a magnetic field substantially perpendicular to the major plane of the free layer or fixed layer.
    Type: Grant
    Filed: October 19, 2012
    Date of Patent: November 21, 2017
    Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Jian-Ping Wang, Md Tofizur Rahman, Yi Wang
  • Patent number: 9823238
    Abstract: The disclosed invention includes methods and kits for the removal of white blood cells from samples of immunomagnetically enriched rare cells by treating the sample with a leukocyte marker conjugated to a hapten which adheres to the white blood cells and treating the resulting product with a second medium that adheres to the hapten of the white blood cells that are labeled with the leukocyte marker conjugated to hapten and removing the labeled white blood cells.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: November 21, 2017
    Assignee: Menarini Silicon Biosystems, Inc.
    Inventors: Galla Chandra Rao, Brad Foulk, Denis Smirnov, Karl Nielsen
  • Patent number: 9790539
    Abstract: Coated Ferromagnetic Density Particles or Density Particles with binding agents bound thereto capable of binding biological molecules and methods of use and apparatus for means are disclosed. Coated particles coupled to specific binding agents can be used for molecular biology and proteomic applications in research and diagnostics.
    Type: Grant
    Filed: June 23, 2005
    Date of Patent: October 17, 2017
    Assignee: Russell Biotech, Inc.
    Inventors: Thomas R. Russell, Michael J. Ciocci, Michael Musick
  • Patent number: 9719925
    Abstract: An apparatus and method are provided for differentiating multiple detectable signals by excitation wavelength. The apparatus can include a light source that can emit respective excitation light wavelengths or wavelength ranges towards a sample in a sample retaining region, for example, in a well. The sample can contain two or more detectable markers, for example, fluorescent dyes, each of which can be capable of generating increased detectable emissions when excited in the presence of a target component. The detectable markers can have excitation wavelength ranges and/or emission wavelength ranges that overlap with the ranges of the other detectable markers. A detector can be arranged for detecting an emission wavelength or wavelength range emitted from a first marker within the overlapping wavelength range of at least one of the other markers.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: August 1, 2017
    Assignee: Applied Biosystems, LLC
    Inventors: Howard G. King, Steven J. Boege, Eugene F. Young, Mark F. Oldham
  • Patent number: 9709579
    Abstract: A microfluidic-based flow assay and methods of manufacturing the same are provided. Specifically, the microfluidic flow assay includes a substrate surface comprising lipid coated particles and microfluidic channels through which a blood product can flow. The lipid coated particles comprise functional molecules that can induce or inhibit the coagulation cascade.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: July 18, 2017
    Assignee: Colorado School of Mines
    Inventors: Keith B. Neeves, Abimbola Onasoga
  • Patent number: 9618518
    Abstract: The current invention relates to a magnetic immunodiagnostic method for the demonstration of antibody/antigen complexes of blood group and phenotype. Such a method involves the research and/or identification of antibodies or antigens, preferably anti-antigen antibodies or antigens of a blood group. This method implements a suspension of magnetic particles coated with an antibody anti-glycophorin A that can recognize and specifically magnetize erythrocytes. The invention also includes a device and kit for carrying out one such method.
    Type: Grant
    Filed: July 21, 2011
    Date of Patent: April 11, 2017
    Assignee: DIAGAST
    Inventors: Laurence Fauconnier, Yves Barbreau, Arnaud Boulet, Maha Zakhour
  • Patent number: 9599591
    Abstract: An integrated sensor that is capable of discriminating the distance of a label from the sensor without using an optical signal. The label is attached to a single probe molecule or a group of probe molecules that interacts with a single or group of target molecules. As a consequence of this interaction, the probe molecule and/or the target molecule undergo a conformal change. This conformal change leads to perturbations in the distance of the label from the sensor. Thus, measurements and properties such as the concentration and the identity of one or more target molecules can be discerned from signals generated by the sensor (or by a plurality of sensors in a sensor array) and subjected to analysis using general purpose programmable computers programmed with suitable software that controls the analytical process, and such measurements and properties can be provided as a result of the analysis.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: March 21, 2017
    Assignee: California Institute of Technology
    Inventors: Alex H. Pai, Stephen A. Chapman, Seyed Ali Hajimiri
  • Patent number: 9575068
    Abstract: A method of detecting a target within a population of molecules comprising: contacting a plurality of labeled probe molecules with the population of molecules potentially containing a target of the probe molecules; acquiring a probe specific signal emitted by said labeled probe molecules that bound to said target together with a background signal; preferentially modulating said probe specific signal by at least one of modulating said acquisition and modulating an emission of said probe specific signal; and detecting said probe specific signal over said background signal using said preferential modulation.
    Type: Grant
    Filed: June 4, 2013
    Date of Patent: February 21, 2017
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Ady Arie, Amos Danielli
  • Patent number: 9535035
    Abstract: Provided are an analysis device and an analysis method. According to the device and the method, a giant magnetoresistance (GMR) sensor unit is formed to be the same as the size of one cancer cell or smaller and magnetic resistance according to the number of magnetic nano particles coupled with the one cancer cell by using the GMR sensor unit, thereby not only diagnosing cancer but also simply and cheaply distinguishing the type of the cancer.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: January 3, 2017
    Assignee: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
    Inventors: Moon Youn Jung, Seungkyoung Yang, Kibong Song
  • Patent number: 9523685
    Abstract: The invention relates to a method for the in vitro diagnostic detection of an infection with a microorganism, comprising placing a biological sample, in a single assay receptacle, in the presence of particles, each carrying at least one specific detectable physical parameter, and belonging to at least two different groups, one of the groups carrying an anti-IgM capture antibody and the other group carrying a capture antigen derived from said microorganism.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: December 20, 2016
    Assignee: BIO-RAD INNOVATIONS
    Inventors: Christine Charpentier, Stephane Gadelle, Nadine Lambert, Amparo Sanjuan
  • Patent number: 9519036
    Abstract: Provided is a magnetic sensor for detecting a magnetic field. The magnetic sensor includes a magnetic layer of a closed loop shape; a pair of current terminals which face each other contacting with the closed loop and through which current is input/output; and a pair of voltage terminals which face each other contacting with the closed loop and from which output voltage is detected. Both an anisotropic magnetoresistance effect (AME) and a planar Hall effect (PHE) contribute to the output voltage and a hysteresis of the output voltage is eliminated by exchange coupling of a ferromagnetic layer by a ferromagnetic-antiferromagnetic layer structure and a ferromagnetic-metal-antiferromagnetic layer structure. Accordingly, it is possible to minimize a hysteresis due to a demagnetization factor of the closed loop, stabilize the output voltage of the magnetic sensor and enhance sensitivity.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: December 13, 2016
    Assignee: THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC)
    Inventors: CheolGi Kim, Dong Young Kim, Jong-Ryul Jeong, Quang Hung Tran
  • Patent number: 9505619
    Abstract: Graphitic nanotubes, which include tubular fullerenes (commonly called “buckytubes”) and fibrils, which are functionalized by chemical substitution, are used as solid supports in electrogenerated chemiluminescence assays. The graphitic nanotubes are chemically modified with functional group biomolecules prior to use in an assay. Association of electrochemiluminescent ruthenium complexes with the functional group biomolecule-modified nanotubes permits detection of molecules including nucleic acids, antigens, enzymes, and enzyme substrates by multiple formats.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: November 29, 2016
    Assignee: MESO SCALE TECHNOLOGIES, LLC.
    Inventors: Richard J. Massey, Mark T. Martin, Liwen Dong, Ming Lu, Alan Fischer, Fabian Jameison, Pam Liang, Robert Hoch, Jonathan K. Leland
  • Patent number: 9488665
    Abstract: Methods for separating, in a continuous, multizone fluid medium, cells, particles, or other molecules of interest (MOI) from associated or contaminating unwanted materials not of interest (MNOI). The invention involves forced movement of MOI into certain zones having properties which deter the entry of unwanted materials. Differential movement of MOI and MNOI occurs by active counterforces that move MNOI but not MOI. MOI are tagged with magnetic particles and moved with a magnetic field through a fluid, or zones, of higher specific gravity that prevents, by flotation counterforce, unwanted less dense materials from entering. Surfaces specifically coated with reactants are reactive with the MOI in the tagged magnetic particle complex and of buoyant or other forces are used to remove any unbound material from the surface before reading.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: November 8, 2016
    Assignee: CHROME RED TECHNOLOGIES, LLC
    Inventors: Henry A. Graham, John G. Gorman, James P. Rowell
  • Patent number: 9448204
    Abstract: In a magnetic immunoassay using AC magnetic susceptibility measurement, a signal from non-coupled magnetic particles is prevented to mix with a desired measurement signal from magnetic particles coupled with an object to be measured. A sample vessel in which a mixed solution of an inspection objective sample and the magnetic particles are included is carried by a sample support, such that a precipitation of the magnetic particle coupled with the object to be measured dispersed in the solution by a magnetic field from a dissociating coil is promoted. Next, the sample vessel is carried to the magnetizing coil and the magnetic signal from the non-coupled magnetic particle remaining in a supernatant in the vessel is peculiarly measured by an MR sensor to perform AC magnetic susceptibility measurement with high precision.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: September 20, 2016
    Assignee: HITACHI, LTD.
    Inventors: Takako Mizoguchi, Ryuzo Kawabata, Akihiko Kandori
  • Patent number: 9448236
    Abstract: The disclosure generally relates to a particulate composition formed from a conductive polymer (e.g., conductive polyanilines, polypyrroles, polythiophenes) bound to magnetic nanoparticles (e.g., Fe(II)- and/or Fe(III)-based magnetic metal oxides). The particulate composition can be formed into a biologically enhanced, electrically active magnetic (BEAM) nanoparticle composition by further including a binding pair member (e.g., an antibody) bound to the conductive polymer of the particulate composition. Methods and kits employing the particulate composition and the BEAM nanoparticle composition also are disclosed.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: September 20, 2016
    Assignee: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
    Inventors: Evangelyn C. Alocilja, Sudeshna Pal, Emma B. Setterington
  • Patent number: 9442110
    Abstract: A system and method are provided to detect target analytes based on magnetic resonance measurements. Magnetic structures produce distinct magnetic field regions having a size comparable to the analyte. When the analyte is bound in those regions, magnetic resonance signals from the sample are changed, leading to detection of the analyte.
    Type: Grant
    Filed: July 15, 2010
    Date of Patent: September 13, 2016
    Assignee: MENON BIOSENSORS, INC.
    Inventors: Suresh M. Menon, David E. Newman, Terry J. Henderson, J. Manuel Perez
  • Patent number: 9383355
    Abstract: Provided is a fluidic device including a main channel, wherein a first inlet fluidly connects to an upstream end of the main channel and introduces magnetic beads into a first side of the main channel. A second inlet is fluidly connected to the upstream end of the main channel and introduces a sample stream into a second side of the main channel. A magnet disposed adjacent to the second side of the main channel pulls the magnetic beads towards a sidewall of the second side, and thus into the sample stream. The beads continue through an extended incubation channel before entering a return channel. The return channel includes a detection region. Also provided is a multi-layer micro-fluidic assay device. An assay method that utilizes a microfluidic assay device is provided as well.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: July 5, 2016
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Lawrence A. Sasso, Jr., Jeffrey Zahn
  • Patent number: 9372156
    Abstract: A system is configured to process the contents of one or more receptacles to detect an optical signal emitted by the contents of each receptacle. Each receptacle is held within a receptacle station of a movable receptacle carrier disposed within a temperature-controlled chamber of an incubator. At least one signal detector is configured to detect an optical signal emitted by the contents of a receptacle as the receptacle carrier moves each receptacle into an operative position with respect to the signal detector. A magnet holder is attached to the receptacle carrier and holds one or more magnets adjacent to an associated receptacle station so as to expose the contents of each receptacle carried in the receptacle station to a magnetic field when the receptacle is in the operative position with respect to the signal detector.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: June 21, 2016
    Assignee: GEN-PROBE INCORPORATED
    Inventor: Byron J. Knight
  • Patent number: 9303049
    Abstract: The present disclosure provides a method for manufacturing a nanodot, including: providing a hydrolysable silane, wherein the hydrolysable silane has one or more hydrolysable groups and one or more substituted or non-substituted hydrocarbon groups; and performing a one-step heat treatment to hydrolyze and condensate the hydrolysable silane to form a nanodot. The nanodot includes: a core, the core is selected from the group consisting of a semiconductor core or a metal core; and a self-assembled monolayer (SAM) including the substituted or non-substituted hydrocarbon groups, wherein the self-assembled monolayer is connected to the core by covalent bonds.
    Type: Grant
    Filed: June 2, 2014
    Date of Patent: April 5, 2016
    Assignee: NATIONAL SUN YAT-SEN UNIVERSITY
    Inventors: Shu-Chen Hsieh, Pei-Ying Lin
  • Patent number: 9260684
    Abstract: A cell culture device comprises a well. A plurality of microwells are within the well, and a first common fluid volume is within the well above the microwells. A set of sub-microwells are within each microwell, and a second common fluid volume is within each microwell above the set of sub-microwells.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: February 16, 2016
    Assignee: Stemcell Technologies Inc.
    Inventors: Oliver Egeler, Steven Woodside
  • Patent number: 9254488
    Abstract: A method and system for selectively processing a sample according to one of a plurality of different assays, for example, for detecting a certain target component in the sample, include a plurality of cartridges in which the processing of a sample can take place and which each contain a different set of reagents required for one of the assays. Moreover, the system further includes a manipulator for introducing a sample into a selected one of the cartridges. Depending on the assay to be performed with a sample at hand, the appropriate cartridge is chosen, and the sample is introduced into and processed in the cartridge.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: February 9, 2016
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Jeroen Nieuwenhuis, Toon Evers
  • Patent number: 9255287
    Abstract: Reaction detection method to detect a chemical reaction with respect to a target substance, for instance, glucose (5) in a sample (32) includes the steps of forming a reaction layer (3) to induce the chemical reaction and forming an oxygen transfer layer (2), which has an oxygen transmission rate higher than that of the reaction layer (3) and which transfers oxygen (4) in the air (1) to the reaction layer (3), between the reaction layer (3) and the air (1), where the oxygen is consumed in the chemical reaction. Chemical reaction rate with respect to target substances in a sample is increased.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: February 9, 2016
    Assignee: SHARP KABUSHIKI KAISHA
    Inventor: Naomi Tomita
  • Patent number: 9206469
    Abstract: Methods and composition for nucleic acid isolation are provided. In one embodiment, a method is provided for nucleic acid purification from biological samples, such as whole blood samples, extracted with phenol-based denaturing solvents, which does not require phase separation or nucleic acid precipitation. Methods according to the invention may also be used for of small RNAs (e.g., siRNAs or miRNAs) purification and are amenable to automation.
    Type: Grant
    Filed: July 17, 2013
    Date of Patent: December 8, 2015
    Assignee: ZYMO RESEARCH CORPORATION
    Inventors: Stanislav Forman, Xiyu Jia
  • Patent number: 9182334
    Abstract: A method for measuring a property of a binding interaction between a capture agent and a binding partner for the capture agent is provided. In certain embodiments, this method comprises: a) contacting a population of particles that are linked to a capture agent with a substrate comprising a binding partner to produce capture agent/binding partner complexes, wherein the population of particles comprises first particles that are bound to a single molecule of the capture agent and second particles that are bound to two molecules of the capture agent; b) applying a force to the bound support, wherein the force is in a direction that separates the particles from the support; and c) separately measuring the forces required to disassociate the first particles and the second particles from their respective complexes.
    Type: Grant
    Filed: February 4, 2013
    Date of Patent: November 10, 2015
    Assignee: Agilent Technologies, Inc.
    Inventor: Bo Curry
  • Patent number: 9167983
    Abstract: A well-posed magnetic imaging method is disclosed that exploits the non-linear behavior of the characteristic time scale of the Néel relaxation for obtaining accurate high-spatial resolution images of magnetic tracers. The method includes placing an object in a selection field (static field) generated by three pairs of orthogonally arranged coil (drive coils), supplying prudently choice currents to the drive coils, a zero field voxel (ZFV) is formed that can be positioned anywhere in the local region of interest (ROI), switching the magnetizing field off, and collecting an image.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: October 27, 2015
    Assignee: THE UNIVERSITY of Houston System
    Inventors: Audrius Brazdeikis, Subhasis Sarangi
  • Patent number: 9157841
    Abstract: A magnetic particle based separation and assaying method uses at least two sets of magnetic particles placed in solution within a container and characterized respectively by a coercive field e1 and e2, wherein e1 is greater than e2. The first magnetic particles with a larger coercive field e1 will be used as carrier to handle the second affinity magnetic particles having a lower coercive field e2. A magnetic particles handling method includes the step of applying an external magnetic field having a polarity and amplitude that varies with time to cause the said carrier magnetic particles to be in relative motion within the container driving thereby the affinity particles to form an homogenous suspension of particles in perpetual relative movement with the respect to the liquid.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: October 13, 2015
    Assignee: Spinomix, S.A.
    Inventor: Amar Rida
  • Patent number: 9144383
    Abstract: A device and methods for the non-invasive manipulation and detection of target objects such as cells, pathogens, microparticles, and nanoparticles in vivo using an external magnetic field are described. In one aspect, a device and method for capturing and detecting intrinsically magnetic target objects or target objects labeled with at least one magnetic particle within the area of interest using an in vivo flow cytometer are described.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: September 29, 2015
    Assignee: The Board of Trustees of the University of Arkansas
    Inventor: Vladimir Pavlovich Zharov
  • Patent number: 9128082
    Abstract: The present invention provides a device for isolating target biomolecules or cells from samples, particularly biological samples. In particular, the device comprises a loading mixture, which contains the biological sample and a first binding entity that specifically binds to the target biomolecule or target cell; and a micro-channel coated with a second binding entity that binds directly or indirectly to the first binding entity. Methods of capturing, detecting, and/or evaluating target biomolecules or target cells (e.g. cancer cells) in biological samples are also disclosed.
    Type: Grant
    Filed: March 24, 2010
    Date of Patent: September 8, 2015
    Assignee: BIOCEPT, INC.
    Inventors: Stephen Mikolajczyk, Tony Pircher, Pavel Tsinberg, Farideh Z. Bischoff
  • Patent number: 9110067
    Abstract: A system and method for analyzing a sample of liquid having an NMR signal in response to a magnetic field for the presence of an analyte. Included is an NMR device having a testing section that is adapted to contain a liquid and apply a magnetic field to the liquid. A complex comprised of a conjugate having a field gradient bound to the analyte that is of sufficient magnitude to quench the NMR signal of the liquid when in the test section whereby the presence of the complex is determined by the absence of the NMR signal.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 18, 2015
    Assignee: The Regents of the University of New Mexico
    Inventor: Laurel Sillerud
  • Patent number: 9110068
    Abstract: A system and method for analyzing a sample of liquid having an NMR signal in response to a magnetic field for the presence of an analyte. Included is an NMR device having a testing section that is adapted to contain a liquid and apply a magnetic field to the liquid. A complex comprised of a conjugate having a field gradient bound to the analyte that is of sufficient magnitude to quench the NMR signal of the liquid when in the test section whereby the presence of the complex is determined by the absence of the NMR signal. The system and method also include a container having a binding agent therein that has an affinity for the analyte or foreign agent that is used to remove the foreign agent from a patient's blood or plasma. Blood or plasma is shunted through the container to remove or reduce the foreign agent by extracorporeal circulation.
    Type: Grant
    Filed: June 6, 2014
    Date of Patent: August 18, 2015
    Assignee: The Regents of the University of New Mexico
    Inventor: Laurel Sillerud
  • Patent number: 9078932
    Abstract: Normal or genetically modified cell(s) having magnetic nanoparticle(s) bound (affixed) to their surfaces and methods of delivery to target tissues, e.g. for treatment of disease and or injury.
    Type: Grant
    Filed: February 4, 2009
    Date of Patent: July 14, 2015
    Assignee: EMMETROPE, INC.
    Inventors: Jeffrey L. Goldberg, Alan Halpern
  • Patent number: 9044729
    Abstract: Methods and devices for amplifying nucleic acids generally involve exposing the nucleic acid to an electromagnetic field, for example a mini-current magnetic field, while performing the steps of PCR. The PCR methods and devices provide numerous advantages over conventional PCR techniques and systems such as reduced reaction times, no heating requirements, and reduced amounts of reagents (e.g., optional use polymerases and primers). Additionally, the PCR methods and devices require significantly shorter reaction times (e.g., less than one hour) compared to conventional PCR techniques and systems (minimum 2 hours). Finally, as shown in the Examples, the PCR methods and devices amplify significantly more DNA compared to conventional PCR techniques and systems. Accordingly, the PCR methods and devices provide a more efficient and cost-effective way to perform PCR when compared to conventional PCR techniques and systems.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 2, 2015
    Assignee: International Park of Creativity
    Inventors: Raul Cuero Rengifo, Mario Antonio Franco Jimenez, Natalia Gutierrez Calle, Mariana Sanchez Londono
  • Publication number: 20150140684
    Abstract: A target affinity material comprising a biodegradable polymer, wherein the biodegradable polymer comprises one or more solid particles and one or more materials that specifically binds to a target, as well as related methods and kits.
    Type: Application
    Filed: July 17, 2014
    Publication date: May 21, 2015
    Inventors: Ga-hee KIM, Hyun-ju Kang, Ye-ryoung Yong, Jong-myeon Park
  • Patent number: 9034660
    Abstract: A first set of antibodies are bonded to a substrate, and are exposed to and bonded with target antigens. A second set of antibodies are bonded to nanoparticles, and the nanoparticle labeled antibodies are exposed to the targeted antigens. An electromagnetic write-head magnetizes the nanoparticles, and then a read-sensor detects the freshly magnetized nanoparticles. The substrate comprises a flexible film or a Peltier material to allow selective heating and cooling of the antigens and antibodies. Nanoparticles of different magnetic properties may be selectively paired with antibodies associated with different antigens to allow different antigens to be detected upon a single scan by the read-sensor.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: May 19, 2015
    Assignee: International Business Machines Corporation
    Inventors: Dylan Joseph Boday, Lee Curtis Randall, Stephen Leonard Schwartz, Anna W. Topol, Daniel James Winarski
  • Patent number: 9023651
    Abstract: The invention relates to a method and a device (100) for determining the amount of a target component (2) in a sample, wherein magnetic particles (2) can bind to a contact surface (4) with kinetics that depend on the sample-amount of the target component. The method comprises at least two washing steps during which magnetic particles (2) are magnetically moved away from the contact surface (4) and corresponding measurements of the remaining amount of magnetic particles (2) at the contact surface (4). The amount of target component in the sample is estimated from at least one of such measurement results. The measurement allows to determine also high concentrations of target component for which the sensor surface (4) is saturated in a steady-state.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: May 5, 2015
    Assignee: Koninklijke Philips N.V.
    Inventors: Toon Hendrik Evers, Wendy Uyen Dittmer